Skip to content

In the BioHarmony Drug Report Database

Promazine

Sparine (promazine) is a small molecule pharmaceutical. Promazine was first approved as Sparine on 1982-01-01. It is used to treat nausea, psychotic disorders, schizophrenia, and vomiting in the USA. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. In addition, it is known to target major prion protein.
Trade Name Sparine
Common Name Promazine
Indication nausea, psychotic disorders, schizophrenia, vomiting
Drug Class Typical antipsychotic
Promazine
Get full access now